Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC

IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology

In Brief for October 12, 2022

… as site for US National Cancer Institute Telehealth Research Center of Excellence. … In Brief for October 12, 2022 …

Arrhythmias after Radiotherapy—What Do (and Don’t) We Know?

… Researchers examine emerging data demonstrating that …

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

… of unresectable pleural mesothelioma. 1  However, research published last month in the  Journal of Thoracic … Vincent’s Hospital, Darlinghurst, Australia, and fellow researchers retrospectively collected demographic and … doi:10.1016/S1470-2045(18)30765-4   … PATIENT RESEARCH ADVOCATE ANGUS PRATT REFLECTS ON THE PAST YEAR OF …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

Step it Up at WCLC 2025 in Barcelona

… audio. Participants can also support the IASLC’s future research initiatives and earn additional points by donating to …

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …

2024 IASLC Academy to Once Again Compete in Amazing Case Race

Antibody Drug Conjugates: Diamonds in the Rough?

… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …